{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T10:59:27Z","timestamp":1724497167575},"reference-count":15,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Flow cytometry and confocal microscopy were used to study the effects of vancomycin, daptomycin, telavancin, and PA1409, a new investigational vancomyquine, on the morphology, membrane potential, and permeability of glycopeptide-susceptible and -resistant\n            <jats:italic>Enterococcus faecalis<\/jats:italic>\n            strains. Daptomycin exerted the most pronounced effects on bacterial size and bacterial permeability against susceptible and resistant strains.\n          <\/jats:p>","DOI":"10.1128\/aac.00970-10","type":"journal-article","created":{"date-parts":[[2010,10,19]],"date-time":"2010-10-19T03:54:41Z","timestamp":1287460481000},"page":"395-398","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":9,"title":["Flow Cytometry as a Tool To Determine the Effects of Cell Wall-Active Antibiotics on Vancomycin-Susceptible and -Resistant\n            <i>Enterococcus faecalis<\/i>\n            Strains"],"prefix":"10.1128","volume":"55","author":[{"given":"Franc\u0327oise","family":"Chau","sequence":"first","affiliation":[{"name":"EA3964, Faculte\u0301 de Me\u0301decine Xavier Bichat, Universite\u0301 Paris 7, F-75018 France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agne\u0300s","family":"Lefort","sequence":"additional","affiliation":[{"name":"EA3964, Faculte\u0301 de Me\u0301decine Xavier Bichat, Universite\u0301 Paris 7, F-75018 France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Benadda","sequence":"additional","affiliation":[{"name":"IFR-02, Faculte\u0301 de Me\u0301decine Xavier Bichat, Universite\u0301 Paris 7, F-75018 France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Dube\u0301e","sequence":"additional","affiliation":[{"name":"EA3964, Faculte\u0301 de Me\u0301decine Xavier Bichat, Universite\u0301 Paris 7, F-75018 France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Fantin","sequence":"additional","affiliation":[{"name":"EA3964, Faculte\u0301 de Me\u0301decine Xavier Bichat, Universite\u0301 Paris 7, F-75018 France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.179.1.97-106.1997"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2009.02.031"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02750-06"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2006.10.003"},{"key":"e_1_3_2_6_2","unstructured":"Performance standards for antimicrobial susceptibility testing; 18th informational supplement. 2009"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01410-07"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.3.1127-1134.2005"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.117.2.360-372.1974"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.3.476"},{"key":"e_1_3_2_11_2","unstructured":"Resistance to daptomycin in vancomycin-resistant Enterococcus faecalis is associated with alterations of cell membrane potential and surface charge 2010"},{"key":"e_1_3_2_12_2","unstructured":"Vancomyquine PA1409: a new hybrid antibacterial molecule 2009"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-7012(95)00089-5"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0320(19990101)35:1<55::AID-CYTO8>3.0.CO;2-2"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-246-5_14"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/421946"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00970-10","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00970-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:54:39Z","timestamp":1645480479000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00970-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1128\/AAC.00970-10"],"URL":"https:\/\/doi.org\/10.1128\/aac.00970-10","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"2010-07-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-10-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}